失调
微生物群
疾病
益生菌
肠道菌群
人类健康
人体微生物群
医学
炎症性肠病
免疫系统
生物
免疫学
生物技术
重症监护医学
生物信息学
细菌
环境卫生
病理
遗传学
作者
Zhao Zhou,Xin Chen,Huakang Sheng,Xiaolin Shen,Xinxiao Sun,Yajun Yan,Jia Wang,Qipeng Yuan
标识
DOI:10.1186/s12934-020-01318-z
摘要
Abstract The gut microbiota that inhabit our gastrointestinal tract are well known to play an important role in maintaining human health in many aspects, including facilitating the digestion and absorption of nutrients, protecting against pathogens and regulating immune system. Gut microbiota dysbiosis is associated with a lot of diseases, such as inflammatory bowel disease, allergy, obesity, cardiovascular and neurodegenerative diseases and cancers. With the increasing knowledge of the microbiome, utilization of probiotic bacteria in modulating gut microbiota to prevent and treat a large number of disorders and diseases has gained much interest. In recent years, aided by the continuous development of tools and techniques, engineering probiotic microbes with desired characteristics and functionalities to benefit human health has made significant progress. In this paper, we summarize the recent advances in design and construction of probiotics as living diagnostics and therapeutics for probing and treating a series of diseases including metabolic disorders, inflammation and pathogenic bacteria infections. We also discuss the current challenges and future perspectives in expanding the application of probiotics for disease treatment and detection. We intend to provide insights and ideas for engineering of probiotics to better serve disease therapy and human health.
科研通智能强力驱动
Strongly Powered by AbleSci AI